Rockwell Medical, Inc. (NASDAQ:RMTI - Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $1.16 and traded as high as $1.67. Rockwell Medical shares last traded at $1.59, with a volume of 2,708,244 shares.
Wall Street Analyst Weigh In
Separately, Wall Street Zen upgraded shares of Rockwell Medical from a "sell" rating to a "hold" rating in a report on Saturday, June 14th. One research analyst has rated the stock with a Strong Buy rating and two have assigned a Buy rating to the stock. According to MarketBeat, Rockwell Medical presently has a consensus rating of "Buy" and an average price target of $4.00.
Get Our Latest Stock Analysis on RMTI
Rockwell Medical Trading Down 1.9%
The stock's fifty day moving average price is $1.15 and its 200 day moving average price is $1.16. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.89 and a quick ratio of 2.51. The stock has a market capitalization of $54.74 million, a P/E ratio of -26.50 and a beta of 1.83.
Rockwell Medical (NASDAQ:RMTI - Get Free Report) last posted its quarterly earnings results on Thursday, August 14th. The company reported ($0.05) EPS for the quarter, hitting analysts' consensus estimates of ($0.05). Rockwell Medical had a negative net margin of 2.38% and a negative return on equity of 6.79%. The firm had revenue of $16.07 million for the quarter, compared to analysts' expectations of $16.33 million. Rockwell Medical has set its FY 2025 guidance at EPS. Research analysts forecast that Rockwell Medical, Inc. will post 0.03 earnings per share for the current year.
Institutional Investors Weigh In On Rockwell Medical
Several hedge funds have recently modified their holdings of RMTI. Raymond James Financial Inc. purchased a new stake in shares of Rockwell Medical in the 4th quarter worth approximately $28,000. Panagora Asset Management Inc. purchased a new stake in shares of Rockwell Medical in the 2nd quarter worth approximately $41,000. Barclays PLC lifted its position in shares of Rockwell Medical by 27.5% in the 4th quarter. Barclays PLC now owns 28,854 shares of the company's stock worth $59,000 after purchasing an additional 6,229 shares during the period. Finally, Dimensional Fund Advisors LP purchased a new stake in shares of Rockwell Medical in the 4th quarter worth approximately $146,000. Hedge funds and other institutional investors own 23.31% of the company's stock.
Rockwell Medical Company Profile
(
Get Free Report)
Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Rockwell Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rockwell Medical wasn't on the list.
While Rockwell Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
